Literature DB >> 32878460

Overdosing on iron: Elevated iron and degenerative brain disorders.

Santosh R D'Mello1, Mark C Kindy2,3.   

Abstract

IMPACT STATEMENT: Brain degenerative disorders, which include some neurodevelopmental disorders and age-associated diseases, cause debilitating neurological deficits and are generally fatal. A large body of emerging evidence indicates that iron accumulation in neurons within specific regions of the brain plays an important role in the pathogenesis of many of these disorders. Iron homeostasis is a highly complex and incompletely understood process involving a large number of regulatory molecules. Our review provides a description of what is known about how iron is obtained by the body and brain and how defects in the homeostatic processes could contribute to the development of brain diseases, focusing on Alzheimer's disease and Parkinson's disease as well as four other disorders belonging to a class of inherited conditions referred to as neurodegeneration based on iron accumulation (NBIA) disorders. A description of potential therapeutic approaches being tested for each of these different disorders is provided.

Entities:  

Keywords:  Alzheimer’s diseases; Parkinson’s disease; iron homeostasis; iron transport; neurodegeneration with brain iron accumulation; neurodegenerative disease

Year:  2020        PMID: 32878460      PMCID: PMC7553095          DOI: 10.1177/1535370220953065

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  488 in total

1.  α-Synuclein Over-Expression Induces Increased Iron Accumulation and Redistribution in Iron-Exposed Neurons.

Authors:  Richard Ortega; Asuncion Carmona; Stéphane Roudeau; Laura Perrin; Tanja Dučić; Eleonora Carboni; Sylvain Bohic; Peter Cloetens; Paul Lingor
Journal:  Mol Neurobiol       Date:  2015-04-02       Impact factor: 5.590

2.  H-ferritin is the major source of iron for oligodendrocytes.

Authors:  Bozho Todorich; Xuesheng Zhang; James R Connor
Journal:  Glia       Date:  2011-03-28       Impact factor: 7.452

Review 3.  Infantile neuroaxonal dystrophy and PLA2G6-associated neurodegeneration: An update for the diagnosis.

Authors:  Alessandro Iodice; Carlotta Spagnoli; Grazia Gabriella Salerno; Daniele Frattini; Gianna Bertani; Patrizia Bergonzini; Francesco Pisani; Carlo Fusco
Journal:  Brain Dev       Date:  2016-11-21       Impact factor: 1.961

Review 4.  Neurodegeneration with brain iron accumulation.

Authors:  Susan J Hayflick; Manju A Kurian; Penelope Hogarth
Journal:  Handb Clin Neurol       Date:  2018

Review 5.  Iron Pathophysiology in Parkinson Diseases.

Authors:  Hong Jiang; Ning Song; Qian Jiao; Limin Shi; Xixun Du
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

6.  Time dependent effects of 6-OHDA lesions on iron level and neuronal loss in rat nigrostriatal system.

Authors:  Jun Wang; Hong Jiang; Jun-Xia Xie
Journal:  Neurochem Res       Date:  2004-12       Impact factor: 3.996

7.  Voxel-based quantitative susceptibility mapping in Parkinson's disease with mild cognitive impairment.

Authors:  Yuto Uchida; Hirohito Kan; Keita Sakurai; Nobuyuki Arai; Daisuke Kato; Shoji Kawashima; Yoshino Ueki; Noriyuki Matsukawa
Journal:  Mov Disord       Date:  2019-05-15       Impact factor: 10.338

8.  Unraveling of the E-helices and disruption of 4-fold pores are associated with iron mishandling in a mutant ferritin causing neurodegeneration.

Authors:  Martin A Baraibar; Barry B Muhoberac; Holly J Garringer; Thomas D Hurley; Ruben Vidal
Journal:  J Biol Chem       Date:  2009-11-18       Impact factor: 5.157

Review 9.  The prion-ZIP connection: From cousins to partners in iron uptake.

Authors:  Neena Singh; Abhishek Asthana; Shounak Baksi; Vilok Desai; Swati Haldar; Sahi Hari; Ajai K Tripathi
Journal:  Prion       Date:  2015       Impact factor: 3.931

Review 10.  The PERK-Dependent Molecular Mechanisms as a Novel Therapeutic Target for Neurodegenerative Diseases.

Authors:  Wioletta Rozpędek-Kamińska; Natalia Siwecka; Adam Wawrzynkiewicz; Radosław Wojtczak; Dariusz Pytel; J Alan Diehl; Ireneusz Majsterek
Journal:  Int J Mol Sci       Date:  2020-03-19       Impact factor: 5.923

View more
  8 in total

Review 1.  Effects of Excess Iron on the Retina: Insights From Clinical Cases and Animal Models of Iron Disorders.

Authors:  Ali Shahandeh; Bang V Bui; David I Finkelstein; Christine T O Nguyen
Journal:  Front Neurosci       Date:  2022-02-03       Impact factor: 4.677

Review 2.  Gut-Brain Axis as a Pathological and Therapeutic Target for Neurodegenerative Disorders.

Authors:  Alma Rosa Lezama Toledo; Germán Rivera Monroy; Felipe Esparza Salazar; Jea-Young Lee; Shalini Jain; Hariom Yadav; Cesario Venturina Borlongan
Journal:  Int J Mol Sci       Date:  2022-01-21       Impact factor: 5.923

Review 3.  A brief history of brain iron accumulation in Parkinson disease and related disorders.

Authors:  Paul B Foley; Dominic J Hare; Kay L Double
Journal:  J Neural Transm (Vienna)       Date:  2022-05-09       Impact factor: 3.850

Review 4.  The Dark Side of Iron: The Relationship between Iron, Inflammation and Gut Microbiota in Selected Diseases Associated with Iron Deficiency Anaemia-A Narrative Review.

Authors:  Ida J Malesza; Joanna Bartkowiak-Wieczorek; Jakub Winkler-Galicki; Aleksandra Nowicka; Dominika Dzięciołowska; Marta Błaszczyk; Paulina Gajniak; Karolina Słowińska; Leszek Niepolski; Jarosław Walkowiak; Edyta Mądry
Journal:  Nutrients       Date:  2022-08-24       Impact factor: 6.706

5.  Correlations Between Iron Status and Body Composition in Patients With Type 2 Diabetes Mellitus.

Authors:  Chen Zimiao; Luo Dongdong; Chen Shuoping; Zhou Peng; Zheng Fan; Chen Rujun; Gong Xiaohua
Journal:  Front Nutr       Date:  2022-07-13

6.  Alterations of the expression levels of glucose, inflammation, and iron metabolism related miRNAs and their target genes in the hypothalamus of STZ-induced rat diabetes model.

Authors:  Edina Pandur; István Szabó; Edina Hormay; Ramóna Pap; Attila Almási; Katalin Sipos; Viktória Farkas; Zoltán Karádi
Journal:  Diabetol Metab Syndr       Date:  2022-10-10       Impact factor: 5.395

7.  Upregulation of brain hepcidin in prion diseases.

Authors:  Suman Chaudhary; Ajay Ashok; Aaron S Wise; Neil A Rana; Dallas McDonald; Alexander E Kritikos; Qingzhong Kong; Neena Singh
Journal:  Prion       Date:  2021-12       Impact factor: 2.547

Review 8.  When Good Kinases Go Rogue: GSK3, p38 MAPK and CDKs as Therapeutic Targets for Alzheimer's and Huntington's Disease.

Authors:  Santosh R D'Mello
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.